Skip to main content
. 2020 May 21;64(6):e00142-20. doi: 10.1128/AAC.00142-20

TABLE 1.

Demographic data, MLST, and antimicrobial susceptibility profile of optrA-positive E. faecalis isolates from swine in Brazila

Isolate State and farm ST optrAb cfr poxtA 23S rRNA and L3/L4 mutations MIC (μg/ml) for:
LZD TZD CHL FFC TGC TET DAP TYL STR SYN ERY CIP PEN VAN NIT GEN KAN
E. faecalis L10 SP piggery B 711 P1 WT 8 1 128 128 0.12 >32 2 >32 >2,048 16 >8 >4 2 2 8 >1,024 >1,024
E. faecalis L11 DF piggery B 591 P1 + WT 8 1 128 128 0.12 >32 2 4 >2,048 16 0.5 2 2 1 32 <128 <128
E. faecalis L12 MG piggery A 711 P1 WT 8 1 128 128 0.25 <1 2 >32 >2,048 >32 >8 1 4 2 16 >1,024 >1,024
E. faecalis L13 SC piggery A 591 P1 WT 8 1 64 128 0.25 >32 1 >32 >2,048 >32 >8 >4 16 2 16 >1,024 >1,024
E. faecalis L15 DF piggery A 591 P1 + WT 8 1 128 128 >0.5 >32 4 >32 >2,048 8 4 2 4 2 16 <128 256
E. faecalis L16 MT piggery A 591 P1 WT 16 1 128 128 0.12 >32 2 >32 >2,048 16 >8 >4 4 1 16 >1,024 >1,024
E. faecalis L18 SC piggery A 591 P1 WT 8 1 128 128 0.25 >32 2 >32 >2,048 16 >8 >4 2 2 16 >1024 >1,024
E. faecalis L21 PR piggery A 591 P1 WT 8 1 128 128 0.12 >32 2 >32 >2,048 16 >8 >4 4 1 16 >1,024 >1,024
E. faecalis L8 SP piggery A 710 P2 WT 8 1 128 128 0.12 >32 2 >32 >2,048 8 4 4 1 1 8 >1,024 >1,024
E. faecalis L14 PR piggery A 330 P3 + WT 8 1 128 128 0.12 >32 2 >32 >2,048 16 >8 >4 4 1 16 >1,024 >1,024
E. faecalis L17 PR piggery A 330 P3 + WT 8 1 128 128 0.12 >32 2 >32 >2,048 16 >8 >4 4 1 16 >1,024 >1,024
E. faecalis L19 PR piggery A 330 P3 WT 8 1 128 128 0.25 >32 2 >32 >2,048 16 2 >4 4 1 32 >1,024 >1,024
E. faecalis L9 DF piggery A 29 P4 + WT 8 1 128 128 >0.5 >32 4 >32 >2,048 8 4 2 4 2 16 <128 256
a

MLST, multilocus sequence typing; WT, wild-type; PR, Paraná; SC, Santa Catarina; DF, Distrito Federal; SP, São Paulo; MG, Minas Gerais; MT, Mato Grosso; LZD, linezolid; TZD, tedizolid; CHL, chloramphenicol; FFC, florfenicol; TGC, tigecycline; TET, tetracycline; DAP, daptomycin; TYL, tylosin; STR, streptomycin; SYN, quinupristin-dalfopristin; ERY, erythromycin; CIP, ciprofloxacin; PEN, penicillin; VAN, vancomycin; NIT, nitrofurantoin; GEN, gentamicin; KAN, kanamycin.

b

Genetic context of optrA.